|
Report Date : |
31.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
KALASIA CO., LTD. |
|
|
|
|
Registered Office : |
Rm.707, Gasan Digital Danji 685, Gasan-dong, Geumcheon-gu,
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
02.12.2009 |
|
|
|
|
Legal Form : |
Co., Ltd by Shares |
|
|
|
|
Line of Business : |
Wholesales of
Pharmaceuticals |
|
|
|
|
No. of Employees : |
6 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company
Name |
KALASIA CO., LTD. (Korean Company Name : “(주)클라시아”) |
|
Registered Address |
685, Gasan-dong,
Geumcheon-gu, |
|
Building |
Rm.707, Gasan Digital Danji |
|
Zip Code |
153-023 |
|
Tel |
+82-2-858-2467 |
|
Fax |
+82-2-858-5572 |
|
E-mail |
garnet8525@kalasia.co.kr;jjang@klasia.co.kr |
|
Website |
|
|
Trading Address |
Rm.707, Gasan Digital Danji, 685, Gasan-dong, Geumcheon-gu, |
|
Tel |
+82-2-858-2467 |
|
Fax |
+82-2-858-5572 |
|
Type |
Export/Import |
|
Industry |
Wholesales of Pharmaceuticals |
|
Main Business |
Raw Materials of Pharmaceuticals,
Consulting Services |
|
Established (mm/dd/yyyy) |
12/02/2009 |
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Raw materials(14101500) |
|
Sell |
Drugs and Pharmaceutical Products(51000000) |
|
Name |
Jeon Jung-Hwui |
|
Address |
|
|
Date of Birth |
10/22/1972 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
|
Capital (KRW) |
50,000,000 |
|
Employees |
6 |
|
Formation |
Co., Ltd by Shares |
|
Bank Details |
N/A |
|
Corporate Registered No. |
121111-0195678 |
|
Business Registered No. |
130-86-47***(The full numbers are kept by
the National Tax Service confidentially.) Because the subject’s full Business
Registered No., for checking through the National Tax Service whether the
subject is still existing or not, is not available, so we cannot confirm if
the subject exist or not legally.) |
|
Permit & Licenses |
N/A |
|
Shareholder Position |
N/A |
|
Company History |
12/02/2009 Incorporated as the present name 03/21/2011 Moved to the present HQ address from
327-27, Gasan-dong, Geumcheon-gu, |
|
|
|
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
President & CEO |
Mr. |
Jeon Jung-Hwui |
Male |
Korean |
12/02/2009 |
|
Director |
Mr. |
You Kyung-Pyo |
Male |
Korean |
12/02/2009 |
|
Auditor |
Mr. |
Noh Si-Cheol |
Male |
Korean |
12/02/2009 |
The financials are
not available, and the Subject Company does not have any obligations to release
its financials to the public.
|
Authorized Capital(KRW) |
200,000,000 |
|
Paid-Up Capital(KRW) |
50,000,000 |
|
Total Issued Shares |
10,000 |
|
Main Products & Services |
Raw Materials of Pharmaceuticals, Consulting
Services |
|
Competitors |
DAEWOONG PHARMA CO., LTD.(134811-0075342) 223-23, SANGDAEWON 1-DONG, JUNGWON-GU, SEONGNAM-SI, TEL:+82-31-741-7700~4
FAX:+82-31-749-5535 ILDONG PHARMACEUTICAL CO., LTD(110111-0012776) 60, YANGJAE 1-DONG, SEOCHO-GU, TEL:+82-2-526-3114
FAX:+82-2-526-3030 DONGWHA PHARM IND CO., LTD.(110111-0043870) 5, SUNHWA-DONG, JUNG-GU, TEL:+82-2-2021-9300 FAX:+82-2-776-7873 |
(Activity &
Markets)
Not Available.
Not Available.
--
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.15 |
|
|
1 |
Rs.81.80 |
|
Euro |
1 |
Rs.68.34 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.